Published in Neurology on October 21, 2016
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Prevalence and most common causes of disability among adults--United States, 2005. MMWR Morb Mortal Wkly Rep (2009) 4.86
Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke (2000) 3.97
Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol (2004) 3.69
Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke (2001) 3.17
Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke (2003) 3.15
Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke (2011) 2.80
IV tissue plasminogen activator use in acute stroke: experience from a statewide registry. Neurology (2006) 2.75
Neurological, functional, and cognitive stroke outcomes in Mexican Americans. Stroke (2014) 2.48
Quality improvement in acute stroke: the New York State Stroke Center Designation Project. Neurology (2006) 2.40
Designing multi-ethnic stroke studies: the Brain Attack Surveillance in Corpus Christi (BASIC) project. Ethn Dis (2004) 2.37
Diagnostic criteria and quality control of the registration of stroke events in the MONICA project. Acta Med Scand Suppl (1988) 2.26
Outcomes after ischemic stroke for hospitals with and without Joint Commission-certified primary stroke centers. Neurology (2011) 2.18
Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation (2010) 2.15
Determinants of use of emergency medical services in a population with stroke symptoms: the Second Delay in Accessing Stroke Healthcare (DASH II) Study. Stroke (2000) 2.14
Comparison of active and passive surveillance for cerebrovascular disease: The Brain Attack Surveillance in Corpus Christi (BASIC) Project. Am J Epidemiol (2002) 1.90
Persistent ischemic stroke disparities despite declining incidence in Mexican Americans. Ann Neurol (2013) 1.79
Older patients with acute stroke in Denmark: quality of care and short-term mortality. A nationwide follow-up study. Age Ageing (2007) 1.77
Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience. Stroke (2003) 1.62
Do the Brain Attack Coalition's criteria for stroke centers improve care for ischemic stroke? Neurology (2005) 1.52
Critical factors determining access to acute stroke care. Neurology (1998) 1.49
Intravenous thrombolysis for stroke increases over time at primary stroke centers. Stroke (2011) 1.46
Stroke care delivery before vs after JCAHO stroke center certification. Neurology (2007) 1.33
Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes (2013) 1.31
Racial disparities in tissue plasminogen activator treatment rate for stroke: a population-based study. Stroke (2011) 1.28
The role of ethnicity, sex, and language on delay to hospital arrival for acute ischemic stroke. Stroke (2010) 1.27
Comparison of stroke hospitalization rates among Mexican-Americans and non-Hispanic whites. Neurology (2000) 1.24
Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis. Stroke (2009) 1.19
Hospital arrival time and intravenous t-PA use in US Academic Medical Centers, 2001-2004. Stroke (2009) 1.18
Older stroke patients in Europe: stroke care and determinants of outcome. Age Ageing (2004) 1.16
Racial and ethnic disparities in the use of intravenous recombinant tissue plasminogen activator and outcomes for acute ischemic stroke. J Stroke Cerebrovasc Dis (2011) 1.03
Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? Cerebrovasc Dis (2009) 0.99
Temporal trends in acute stroke management. Stroke (2013) 0.99
Thrombolysis for acute ischemic stroke in Joint Commission-certified and -noncertified hospitals in Michigan. J Stroke Cerebrovasc Dis (2013) 0.87
Marked Regional Variation in Acute Stroke Treatment Among Medicare Beneficiaries. Stroke (2015) 0.86
Resource utilization and outcome at a university versus a community teaching hospital in tPA treated stroke patients: a retrospective cohort study. BMC Health Serv Res (2010) 0.85